The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
          View 
        
      Event
    
      2023 CPhI Worldwide
    
        Date:
        
            2023/10/24
                        to 2023/10/26
                      
        Location:
        Barcelona, Spain
      
          View 
        
      Event
    
      2023 CPhI North America
    
        Date:
        
            2023/04/25
                        to 2023/04/27
                      
        Location:
        Philadelphia, USA
      
          View 
        
      Event
    
      Webinar: ASDs by Spray Drying: Process Development & Scale-Up
    
        Date:
        
            2023/03/22
                      
        Location:
        online
      
          View 
        
      Event
    
      2022 CPhI Worldwide
    
        Date:
        
            2022/11/01
                        to 2022/11/03
                      
        Location:
        Frankfurt, Germany
      
      View

Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmicShowing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction

      View

News / Apr 28, 2021
World Day for Safety and Health at WorkSafety First, Quality Always

      View

Press Release / Nov 29, 2023
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDCHovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.

      View

Press Release / Feb 25, 2022
Jean-Luc Herbeaux to become Hovione CEOHovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022

      View

Press Release / Jan 16, 2025
Hovione strengthens its global position as a  top employer for the third consecutive yearHovione has once again solidified its position as a top employer.

      View

News / Mar 10, 2021
It's B Corp MonthWe are proud to be a B Corporation.

Browser not supported

Search

Types

Press Room

Categories

2023 CPhI Worldwide

2023 CPhI North America

Webinar: ASDs by Spray Drying: Process Development & Scale-Up

2022 CPhI Worldwide

Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic

World Day for Safety and Health at Work

Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC

Jean-Luc Herbeaux to become Hovione CEO

Hovione strengthens its global position as a top employer for the third consecutive year

It's B Corp Month